🕵️ Passage BIO, Inc. ($PASG)
SEC insider & ownership activity, last 12 months · CIK 1787297 · every row links its SEC filing
Over the last 12 months insiders sold $113K against $430K of open-market buying. LYNX1 Capital Management LP bought $430K (Sep–Jun). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
1 buyer, $430K (4 lots) · 2 sellers, $113K (2 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| LYNX1 Capital Management LP | 4 | $430K | 0 | – | Jun 25, 2026 |
| Chou William | 0 | – | 1 | $75K | Jan 8, 2026 |
| Borthwick Kathleen | 0 | – | 1 | $38K | Jan 8, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| LYNX1 Capital Management LP | 21.0% | 13D | Jun 25, 2026 | filing ↗ | |
| Weston Nichols | 21.0% | 13D | Jun 25, 2026 | filing ↗ | |
| LYNX1 Capital Management LP | 19.6% | 13G | Nov 14, 2025 | filing ↗ | |
| Weston Nichols | 19.6% | 13G | Nov 14, 2025 | filing ↗ | |
| Orbimed Advisors LLC | 12.0% | 13D | Dec 20, 2024 | filing ↗ | |
| Orbimed Capital GP VII LLC | 12.0% | 13D | Dec 20, 2024 | filing ↗ | |
| Baselake Partners, LP | 7.3% | 13G | Jun 25, 2026 | filing ↗ | |
| Baselake Management, LLC | 7.3% | 13G | Jun 25, 2026 | filing ↗ | |
| David Paolella | 7.3% | 13G | Jun 25, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Chou William | $75K | Jan 9, 2026 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Material agreement (1.01) | Jun 23, 2026 | filing ↗ |
| Agreement terminated (1.02) | Jun 23, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Jun 23, 2026 | filing ↗ |
| Change of control (5.01) | Jun 23, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jun 23, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 23, 2026 | filing ↗ |
| Other events (8.01) | Jun 23, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 23, 2026 | filing ↗ |
| Agreement terminated (1.02) | May 21, 2026 | filing ↗ |
| Shareholder vote (5.07) | May 19, 2026 | filing ↗ |
| Exit or disposal costs (2.05) | Apr 28, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Apr 20, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 20, 2026 | filing ↗ |
| Agreement terminated (1.02) | Mar 4, 2026 | filing ↗ |
| Earnings (2.02) | Mar 3, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 3, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 3, 2026 | filing ↗ |
| Earnings (2.02) | Jan 12, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jan 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 12, 2026 | filing ↗ |
| Earnings (2.02) | Nov 10, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Nov 10, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 10, 2025 | filing ↗ |
| Officer/director changes (5.02) | Sep 16, 2025 | filing ↗ |
| Earnings (2.02) | Aug 12, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Aug 12, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 12, 2025 | filing ↗ |